Merger with Nasdaq-listed Nabi the perfect drug for Biota – The Australian
|
Merger with Nasdaq-listed Nabi the perfect drug for Biota
The Australian PETER Cook has spent enough time in the US in recent months to be convinced that Biota's merger with the Nasdaq-listed Nabi Biopharmaceuticals is the right move. The bankers, investment managers and analysts that the Biota chief executive meets all … |
